---
type: process
aliases: [translation, mRNA translation, proteome synthesis]
key-proteins: ["[[eif2alpha]]", "[[4ebp1]]", "[[s6k1]]", "EIF4E"]
pathways: ["[[mtor]]", "[[integrated-stress-response]]"]
hallmarks: ["[[loss-of-proteostasis]]", "[[deregulated-nutrient-sensing]]"]
selective-variants: []
druggability-tier: 1
caused-by: ["[[ribosome-biogenesis]]", "[[mtor]]"]
causes: []
literature-checked-through: 2026-08-09
verified: true
verified-date: 2026-08-09
verified-by: claude
verified-scope: "Initiation/elongation/termination and cytosolic-versus-mitochondrial topology checked against Reactome R-HSA-72766; mTOR–4E-BP1/S6K1 and eIF2alpha-ISR control checked against Fingar 2004 and Palam 2011 full text; Li 2025 synthesis, clearance and intervention claims taken from the fully verified study extraction. Aging-context tier and literature recency/supersession checked through 2026-08-09."
---

# Protein synthesis

Protein synthesis translates mRNA into a polypeptide through initiation, elongation and termination. Cytosolic translation, ER-targeted cotranslational translocation and mitochondrial translation use related but distinct machinery [^reactome-translation]. This page treats their shared output while preserving those compartment boundaries.

[[mtor|mTORC1]] promotes cap-dependent initiation by phosphorylating the translational repressor [[4ebp1|4E-BP1]] and activating [[s6k1|S6K1]] [^fingar2004]. During the [[integrated-stress-response]], stress-sensing kinases phosphorylate [[eif2alpha|eIF2alpha]] at Ser51, reducing general initiation while permitting selective translation of stress-response mRNAs such as *ATF4* and *CHOP* [^palam2011]. Thus protein synthesis is regulated at both global and transcript-selective levels; an increase in one assay does not establish improved proteome output or fidelity.

## Oocyte and cumulus-cell evidence

Li et al. observed increased nascent-protein labeling and mTOR activity in older human cumulus cells together with reduced lysosomal/proteasomal programs and more protein aggregates. Rapamycin or cycloheximide reduced translation and selected senescence/aggregate proxies in culture. Aged mouse cumulus–oocyte complexes treated with 0.5 μM rapamycin during maturation had lower pS6, oxidative stress and spindle/chromosome abnormalities and higher maturation [^li2025]. These were ex vivo experiments, not in-vivo rejuvenation of a mouse ovary.

The same paper found ribosomal transcript enrichment in older human oocytes, but only a slight, nonsignificant aggregate difference in oocytes themselves. Cumulus-cell data should not be generalized to oocytes without qualification. Homopropargylglycine incorporation measures nascent-protein production; it does not by itself identify the translated proteins, their folding/fidelity or their later clearance.

## Synthesis, turnover and aging interpretation

Translation is the synthesis arm of proteome flux. Protein abundance and aggregate burden additionally depend on folding, trafficking and degradation through the proteasome, lysosome and autophagy. Li measured higher synthesis labeling together with lower lysosomal signal/transcript programs and more cumulus-cell aggregates, but did not perform a full synthesis-versus-degradation turnover decomposition or directly measure translational fidelity. The proposed production/clearance imbalance is therefore supported but not quantitatively resolved.

Aging direction is context- and cell-state-dependent: excessive synthesis relative to quality-control capacity can be proteotoxic, while insufficient synthesis can limit repair and renewal. Li supports excess relative synthesis in one reproductive-cell setting, not a universal aging rule.

## Druggability

This process is **aging-context tier 1 indirectly** because clinical mTOR inhibitors can reduce translation and have aging-relevant human trial exposure. They are not translation-selective: rapamycin also affects autophagy, metabolism and stress signaling, and the Li trial did not establish live-birth efficacy or long-term reproductive safety.

## Footnotes

[^reactome-translation]: Reactome R-HSA-72766, Translation (Homo sapiens), reviewed canonical pathway, current through 2026-08-09
[^fingar2004]: doi:10.1128/MCB.24.1.200-216.2004 · Fingar DC et al. · *Mol Cell Biol* 2004;24:200–216 · primary mammalian-cell study of parallel mTOR-dependent S6K1 and 4E-BP1/eIF4E signaling
[^palam2011]: doi:10.1074/jbc.M110.216093 · Palam LR, Baird TD, Wek RC · *J Biol Chem* 2011;286:10939–10949 · primary mechanistic study of eIF2 phosphorylation, general translation repression and selective stress-response translation
[^li2025]: [[studies/li-2025-ribosome-age-related-infertility]] · doi:10.1016/j.xcrm.2025.102424 · Li J et al. · *Cell Reports Medicine* 2025;6:102424
